Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound - Wikidata - awgldk - TriplyDB

Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound

Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound

http://www.wikidata.org/entity/Q30463873

about

Improving the performance of phase-change perfluorocarbon droplets for medical ultrasonography: current progress, challenges, and prospects.Phase-transition thresholds and vaporization phenomena for ultrasound phase-change nanoemulsions assessed via high-speed optical microscopy.Selective Vaporization of Superheated Nanodroplets for Rapid, Sensitive, Acoustic Biosensing.Human concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptake.Ultrasound-enhanced drug delivery for cancer High-intensity focused ultrasound ablation enhancement in vivo via phase-shift nanodroplets compared to microbubbles.Stable Encapsulation of Air in Mesoporous Silica Nanoparticles: Fluorocarbon-Free Nanoscale Ultrasound Contrast Agents Optically and acoustically triggerable sub-micron phase-change contrast agents for enhanced photoacoustic and ultrasound imaging Super-Resolution Ultrasound Imaging in Vivo with Transient Laser-Activated Nanodroplets.Selective intracellular vaporisation of antibody-conjugated phase-change nano-droplets in vitro Ultrasound mediated delivery of oxygen and LLL12 loaded stimuli responsive microdroplets for the treatment of hypoxic cancer cells.Laser irradiated fluorescent perfluorocarbon microparticles in 2-D and 3-D breast cancer cell models Nanoparticles Formed by Acoustic Destruction of Microbubbles and Their Utilization for Imaging and Effects on Therapy by High Intensity Focused Ultrasound.Monitoring/Imaging and Regenerative Agents for Enhancing Tissue Engineering Characterization and Therapies An evaluation of the sonoporation potential of low-boiling point phase-change ultrasound contrast agents in vitro Targeted Transthoracic Acoustic Activation of Systemically Administered Nanodroplets to Detect Myocardial Perfusion Abnormalities Phase-Conversion Nanoparticle Contrast Agents: Do Good Things Come in Small Packages?Lipid Coated Microbubbles and Low Intensity Pulsed Ultrasound Enhance Chondrogenesis of Human Mesenchymal Stem Cells in 3D Printed Scaffolds Biodegradable polymeric nanoparticles containing gold nanoparticles and Paclitaxel for cancer imaging and drug delivery using photoacoustic methods.Vaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validation Phase-change contrast agents for imaging and therapy.Nanodroplet-Vaporization-Assisted Sonoporation for Highly Effective Delivery of Photothermal Treatment.Application of acoustic droplet vaporization in ultrasound therapy.Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.State-of-the-art materials for ultrasound-triggered drug delivery.Phase-shift perfluorocarbon agents enhance high intensity focused ultrasound thermal delivery with reduced near-field heating.Engineering optically triggered droplets for photoacoustic imaging and therapy In vitro parameter optimization for spatial control of focused ultrasound ablation when using low boiling point phase-change nanoemulsions.Synthesis of phase-shift nanoemulsions with narrow size distributions for acoustic droplet vaporization and bubble-enhanced ultrasound-mediated ablation India ink incorporated multifunctional phase-transition nanodroplets for photoacoustic/ultrasound dual-modality imaging and photoacoustic effect based tumor therapy Assessment of the biodistribution of an [(18) F]FDG-loaded perfluorocarbon double emulsion using dynamic micro-PET in rats.Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle The impact of vaporized nanoemulsions on ultrasound-mediated ablation Acoustic droplet vaporization in biology and medicine.Nanodroplet-mediated histotripsy for image-guided targeted ultrasound cell ablation Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.Potential and problems in ultrasound-responsive drug delivery systems.Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons.Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging Phase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures.

P2860

Q26861530-67A3D313-503F-4DE6-B2FC-CA0CED7A822A Q27308582-3F20EF55-BE3C-4F42-9D26-AE19AEED9AD3 Q27342508-E18EE2A0-3474-450C-B023-7D61C320B547 Q28486221-C533616D-F88F-4DED-B636-1C04E6A6EC75 Q29035807-F17C6472-A02E-43B1-8311-8E682F67DFA5 Q30279234-A4099EA8-99F6-4920-92EE-40BBE3DE3F9D Q30354951-FC8D74C0-706A-4398-B57E-E0435A05637A Q30356325-EFFFD979-BBC0-4EF9-893C-C28F30040917 Q30358789-76289837-8756-4ECE-B63C-FDB2944BE607 Q30360403-0FA8B38A-DEA3-4F24-855A-4B1A8C08D27E Q30360565-3C3A3449-0F46-4EBD-820B-E0C033E18856 Q30361592-5FBCACD9-72E7-4352-AD0C-9DDA4E9BD1D4 Q30361996-9F35F228-B90A-4EA7-ADFC-32E1840B216D Q30362056-50228D5E-FC80-4F00-8580-8F84ECE8E902 Q30364987-DAA401C1-0AFF-46C9-8BB2-6490F0F8405C Q30366665-231B2E85-424F-4BDA-8B3F-AD8DFDEECF22 Q30366668-9534E0D4-032C-46B0-B40A-3CFC9D61D2AA Q30369153-DB064F39-80AD-4EA5-9AB9-A7D581F85167 Q30369570-3CE3834B-5ADD-403C-AC37-67B3C3624E17 Q30370707-D9D9500F-7836-4DCA-8DA7-BE305950A9BB Q30373053-2295D51E-15E6-4A36-8D56-F9393675A698 Q30385124-4C67F30B-CE35-421C-BA5F-48673476CD61 Q30398863-0CD24884-EDF2-4BBF-AEEE-16534AB8B350 Q30408959-8B99E597-578E-423A-9180-680DD9F045B6 Q30409234-320DDF98-0940-4F33-A838-A043A7C71902 Q30411555-DFE692FC-66B1-4E2A-BB87-FE60759177F5 Q30421094-161C4558-FABC-4FE0-998A-2A3A1E108430 Q30422879-9875B7F0-57AE-4839-996D-3A19EC15B39F Q30430901-6410B5E1-546B-4902-83EE-8EF8E6E4E7E6 Q30432452-1418CBD8-3566-4820-BED0-BBF3E436B9C7 Q30435595-6F0A5460-1237-4C41-AD6B-E6EC4A2A156D Q30439339-4DBFB2E4-120C-46B3-9FDC-560DB77768F7 Q30440014-C22E97EE-45B5-41FB-B7C8-6AB8EBEF7FB2 Q30445721-EC5CEEEB-DE6F-4A22-A5CE-D228B3C4C8B5 Q30446270-622331D9-75B2-4389-AC0A-3BE16056C054 Q30450131-9FBDB97D-3AD4-4C39-B7F5-14F420F5D817 Q30454986-613BD508-0180-4ABB-ACD6-C03E888F39D4 Q30455782-EAE6CEE8-35DC-4877-8423-0C85E2758DFB Q30458493-8A0CCED7-7D55-451F-A9B3-FB15EE0556B3 Q33898006-A8FE099C-B1AB-4242-A912-4E5163121777

P2860

Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound

http://www.wikidata.org/entity/Q30463873

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Formulation and acoustic studi ...... tic and therapeutic ultrasound

@ast

Formulation and acoustic studi ...... tic and therapeutic ultrasound

@en

type

label

Formulation and acoustic studi ...... tic and therapeutic ultrasound

@ast

Formulation and acoustic studi ...... tic and therapeutic ultrasound

@en

prefLabel

Formulation and acoustic studi ...... tic and therapeutic ultrasound

@ast

Formulation and acoustic studi ...... tic and therapeutic ultrasound

@en

P1433

Q30463873-708ECF27-1DFF-493E-98EF-BC6A3AAFA781

P1476

Q30463873-42E533FA-66E6-4E17-9AF7-E68242D33782

P2093

Q30463873-64101293-8DCC-4909-8BCA-05BD73B2D137

Q30463873-7AB5DA24-9460-44EE-9B89-CBC009CF5D8E

Q30463873-E5AE3918-CCA1-4120-9C10-FA07C0DF3766

P2860

Q30463873-0B66FCAE-9681-47EE-8EE8-023591FB4F49

Q30463873-10E1EA51-BFAE-45DF-AAB7-3E017475FD81

Q30463873-1BFF8FC6-D832-49FC-877E-7BB0A702AB0E

Q30463873-20E02D93-F65D-40ED-BF63-103724004DEC

Q30463873-23F05F51-B8AA-41A1-8D9E-08197A327EF9

Q30463873-2BDA2100-2323-4E0F-A247-A837F1BE5A90

Q30463873-38DBF6D6-E839-4582-B9E6-CFA5C5739657

Q30463873-402810FA-5F19-45DD-B298-A13D3719E88C

Q30463873-4E87EBF0-D7D2-4D9B-BC48-99333B503C4C

Q30463873-5DB2800D-62B3-45DE-A1C7-39F78E4D83EE

P304

Q30463873-7BB6B95B-C8EA-47E7-B924-00A5DE60BDB9

P31

Q30463873-DA752471-56B2-4916-90F8-53C0E5068C0E

P356

Q30463873-03458891-EA35-47CF-8CFF-B6CB71313EBD

P407

Q30463873-9D7C1C83-54A7-4868-B222-FB0673505911

P433

Q30463873-B8B3BE65-2B25-41F7-BDB2-625E5386EEC0

P478

Q30463873-0DA1342D-3463-4B3B-8ACC-AEF08C6D08B2

P50

Q30463873-1D23C218-6366-4E35-83A5-AD05AA900AB1

P577

Q30463873-7F0AE0B0-7C65-4F60-BECF-7A5D4473B3C1

P5875

Q30463873-C69B3B49-9E2A-4784-B412-F1E714252A8B

P698

Q30463873-2C17A099-2205-4A1F-962C-BCF74D5DCDEA

P921

Q30463873-1fcfba4a-8e06-4e2b-bfab-15b04bf22230

P932

Q30463873-42C55328-C804-4D4C-8907-36AEF1F76EFE

P356

P1433

P1476

Formulation and acoustic studi ...... tic and therapeutic ultrasound

@en

P2093

Paul A Dayton

http://www.w3.org/2001/XMLSchema#string

Samantha Luois

http://www.w3.org/2001/XMLSchema#string

Terry O Matsunaga

http://www.w3.org/2001/XMLSchema#string

P2860

Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging.

Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.

Effect of anesthesia carrier gas on in vivo circulation times of ultrasound microbubble contrast agents in rats

Initial investigation of acoustic droplet vaporization for occlusion in canine kidney.

Advances in molecular imaging with ultrasound

The role of inertial cavitation in acoustic droplet vaporization.

Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?

Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles.

Transmitted ultrasound pressure variation in micro blood vessel phantoms.

On the acoustic vaporization of micrometer-sized droplets.

P304

10412-10420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/LA2013705

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51482365

http://www.w3.org/2001/XMLSchema#string

P698

21744860

http://www.w3.org/2001/XMLSchema#string

P921

P932

3164903

http://www.w3.org/2001/XMLSchema#string